Slovo úvodem

MUDr. Lucie Růžičková Jarešová

Dermatol. praxi. 2013;7(2):47  

Contact facial eczema - contact allergens

doc.MUDr.Eliška Dastychová, CSc.

Dermatol. praxi. 2013;7(2):50-55  

Factors that allow the development of contact sensitisation in the facial area include irritation with external stimuli (i. e. climatic factors including UV radiation, skin washing and cleansing, occupational factors) as well as the presence of dermatosis, particularly atopic eczema, seborrhoeic dermatitis and rosaceiform dermatitis. The most common contact allergens in the facial area include components contained in cosmetic products. Both active substances and excipients and perfumes can be involved. Sensitisation to active substances in hair dyes, particularly to those that are among para-amino compounds, i. e. paraphenylenediamine, 4-toluenediamine...

Diffuse hair thinning

MUDr.Renata Kučerová, Ph.D.

Dermatol. praxi. 2013;7(2):56-59  

Aetiopathogenetic aspects Diffuse hair loss is a common condition and a cause of mental problems in affected women and men. An understanding of individual types of hair loss is based on the knowledge of hair cycle physiology. Differential diagnosis involves a distinction of telogen effluvium from anagen (or dystrophic anagen) effluvium as well as of androgenic alopecia that has a typical clinical presentation.

Supportive treatment of acne vulgaris - part of a comprehensive treatment

MUDr.Eliška Langerová

Dermatol. praxi. 2013;7(2):61-65  

Acne vulgaris is a chronic inflammatory androgen-dependent disease of pilosebaceous unit. It is one of the most frequent diseases at all. Nearly one hundred percent of population is affected by this disease with multifactorial etiopathogenesis. Its social impact is very serious. Clinical appearance differs in patients. There exists many classification systems which influence the treatment. The therapy is usually combined to focus on all etiological factors. Beside the classical topical, systemic and physical treatment is also important supportive therapy. This therapy does not include only cosmetics, but aims at the personality of individuals,...

The effect of naftifine on mycoses and its comparison to other antimycotics

MUDr.Jiří Slíva, Ph.D.

Dermatol. praxi. 2013;7(2):66-68  

Locally acting antimycotics are commonly used in the treatment of superficial skin infections including tinea corporis, tinea cruris, and tinea pedis etc. Naftifine is an allylamine substance, which has been used, like azoles, in many countries. Comparing to azoles, it should offer a shorter duration of treatment. In this article, most relevant so far published clinical trials with naftifine in approved indications are discussed.

DMS (Derma Membrane Structure) technology and its positive effects on skin hydration

doc.PharmDr.Mgr.David Vetchý, Ph.D.

Dermatol. praxi. 2013;7(2):69-72  

Currently, the stratum corneum is regarded as a “wall”, the “brick” consists of corneocytes and “mortar” lamellar lipid membrane. Since it appears that disturbances in the function of the barrier play a fundamental role in the pathogenesis of irritable eczema, atopic dry skin and aging skin, should be the primary goal improve the function of skin lipid barrier in these diseases. DMS (Derma Membrane Structure) technology is a unique patented process by which is prepared cream absolutely neutral, imitating the lamellar structure of the stratum corneum as lipid content as well as the lamellar structure, and...

Mutilating form of psoriatic spondylitis

MUDr.Marcela Brenerová, MUDr.Alena Machovcová, MBA, MUDr.Yvetta Vantuchová, Ph.D.

Dermatol. praxi. 2013;7(2):73-76  

Case report describes a 57-year-old man with a long-term chronic psoriasis treated only with methotrexate in combination with non-steroidal anti-inflammatory drugs. In relatively short time psoriasis has transformed into psoriatic spondylitis and psoriatic arthropathy of the fifth degree. This case shows how important it is to start proper treatment earlier before appears irreversible change in joints. Early recognition of psoriatic arthritis by dermatologist and close cooperation with the rheumatologist may significantly affect the prognosis and quality of life.

Psychotherapy approach in patient with psoriasis

PhDr.Alena Javůrková, Ph.D., PhDr.Jaroslava Raudenská, Ph.D.

Dermatol. praxi. 2013;7(2):77-78  

The article focuses on using psychotherapy in terms of multidisciplinary treatment of psoriasis. Rises from biopsychosocial model of dermatosis. Describes case-study, which demonstrates effect of psychosocial factors in formation, course and exacerbation of disorder and concequences of psoriasis to quality of life. In patients, which cope with dermatology illness maladaptivelly, the dermatologist has following possibilities: the patient specifies problem her/himself, or manage the problems of patient connected to skin to find out together with team. Part of the team can be clinical psychologist, which use psychological assessment and spectrum...

Differential diagnosis and treatment of lower limb oedema

MUDr.Zuzana Navrátilová, Ph.D.

Dermatol. praxi. 2013;7(2):79-80  

The article briefly deals with the diagnosis and treatment of lower limb oedema with a particular emphasis on oedema of venous and lymphatic origin.

Atopic dermatitis - over-the-counter drugs

PharmDr.Jan Hašek

Dermatol. praxi. 2013;7(2):81-85  

Local anti-inflammatory agents and emollients are used to treat atopic dermatitis. Emollients are the mainstay of treatment and they are part of everyday skin care for atopic patients. It includes a wide range of over-the-counter medicinal products and therapeutic cosmetics. Hydrocortisone is the only local corticosteroid sold over the counter. Also available are products containing ichthammol, including the cosmetically more acceptable variants of white ichthammol. When atopic eczema is accompanied by type I allergy, some antihistamines are available. Key wors: over-the-counter drugs, atopic dermatitis, emollients, moisturizing substance,...

Stárnutí kůže

MUDr. Lucie Růžičková Jarešová

Dermatol. praxi. 2013;7(2):86-87  

Zpráva ze 71. výročního mítinku Americké akademie dermatologie v Miami, 1.-5. 3. 2013

doc. MUDr. Karel Ettler, CSc.

Dermatol. praxi. 2013;7(2):89-90